SAM
Simplify Asset Management Portfolio holdings
AUM
$4.93B
1-Year Est. Return
7.16%
1 Year Est. Return
+7.16%
AUM
$4.93B
AUM Growth
+$3.28B
(+199%)
Holding
137
Top Buys
| 1 | +$3.32B | |
| 2 | +$41.3M | |
| 3 | +$26.1M | |
| 4 |
Simplify Multi-QIS Alternative ETF
QIS
|
+$13.4M |
| 5 |
UnitedHealth
UNH
|
+$8.74M |
Top Sells
| 1 | +$80M | |
| 2 | +$39M | |
| 3 | +$30.7M | |
| 4 |
Simplify Aggregate Bond ETF
AGGH
|
+$30.5M |
| 5 |
NMB
Simplify National Muni Bond ETF
NMB
|
+$29.3M |
Sector Composition
| 1 | Healthcare | 3.63% |
| 2 | Energy | 0.48% |
| 3 | Consumer Discretionary | 0.36% |
| 4 | Technology | 0.19% |
| 5 | Industrials | 0.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
QVCGA
126
QVC Group Inc Series A
QVCGA
$79M
| $162K | ﹤0.01% |
12,000
|
|
||
127
Agilon Health
AGL
$423M
| $117K | ﹤0.01% |
113,976
+13,824
|
|
||
128
SPDR Gold Trust
GLD
$157B
| – | – |
0
|
|
||
129
Insulet
PODD
$20.2B
| – | – |
-1,006
|
|
||
130
Ultragenyx Pharmaceutical
RARE
$2.26B
| – | – |
-15,210
|
|
||
131
ADMA Biologics
ADMA
$4.16B
| – | – |
-381,139
|
|
||
132
Capricor Therapeutics
CAPR
$1.32B
| – | – |
-40,000
|
|
||
133
Quest Diagnostics
DGX
$21.1B
| – | – |
-8,161
|
|
||
134
DexCom
DXCM
$27.4B
| – | – |
-20,650
|
|
||
135
Fluor
FLR
$7.12B
| – | – |
-68,174
|
|
||
136
ResMed
RMD
$37.9B
| – | – |
-10,005
|
|
||
137
Sanofi
SNY
$113B
| – | – |
-20,716
|
|